Articles
Biotech's natural selectors
One of the spin-offs of Australia's burgeoning biotech sector is an increasingly competitive recruitment sector. [ + ]
Power pool: how grid computing can benefit bio
Distributed processing gets an updated look as vendors go for the grid: In early 2000, Cereon Genomics had a serious situation on its hands: It was running out of computing power. [ + ]
Stan Yakatan: The paradigm shifter
Stan Yakatan, "US venture capital raising guru" and strategic biotechnology adviser to the Victorian government, sits at a table in The Westin Melbourne's Allegro restaurant surrounded by breakfast, documents and five chairs intermittently filled and vacated biotech movers and shakers. [ + ]
VC's biotech interest hits new heights
Venture capitalists complain they are finding it ever-tougher to coax fresh funds from investors. Yet paradoxically, the total Australian pool of life science risk capital stands at record levels. [ + ]
The language of biobusiness
Spend any time in the biobusiness sector and you learn one thing very quickly: it pays to be bilingual. And not in French or Spanish or Japanese, but in the languages of science and money. [ + ]
Dr Tom Schneider: Wake up and smell the apple pie: we need the US
Barely a week goes by when an overseas business expert isn't out here telling Australian companies how it should be done. [ + ]
Growth Industry
Plant genetics is a driving force in agricultural biotech in Australia, affecting the commercial crop industries, horticulture, forestry and viticulture. Even livestock industries have plant biotechnology programs to develop improved pasture crops. [ + ]
Give programs time to mature: Radke
Calls for the government to initiate further commercialisation programs were premature, according to Commonwealth industry body Biotechnology Australia. [ + ]
Separation anxiety: drawing the line between funding and commercialisation
A debate is emerging over where to draw the line on use of basic research funding sparked by the wholesale push towards commercialisation of Australian research. [ + ]
Studying corrosion phenomena
Described as the biggest advance in microscopy since the electron microscope, the second-generation scanning Kelvin probe has been unveiled by Australian scientists
[ + ]Bioinformatics: Lights on, no one home?
Pilots, not planes, are needed to get Australia's nascent bioinformatics industry off the ground, according to one of the authors of a new report. [ + ]
Bio gold rush could pay off for enterprise IT
Like most of us, IT managers at major retailing or banking companies probably find the current revolution in life sciences research compelling because of its promise to disarm hereditary diseases or cancers. But they may not realise that they also have a professional self-interest in computationally driven work on genetics, proteins, and pharmaceuticals. [ + ]
Biotech's golden child is still in utero
Like a gold-plated corkscrew, bioinformatics is all about unplugging the data bottleneck that clogs drug R&D pipelines. [ + ]
Interview: Life science 'the next big thing, says IBM's Kovac
IDG spoke with Dr Caroline Kovac, general manager of IBM Life Sciences Solutions, about her company's involvement in the life sciences. [ + ]
Australian research makes a play in the post-genomic era
In the biggest party the science community has ever seen, Australia was a wallflower. [ + ]
